000 01494 a2200397 4500
005 20250515152736.0
264 0 _c20090316
008 200903s 0 0 eng d
022 _a1551-4005
024 7 _a10.4161/cc.7.24.7245
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZenz, Thorsten
245 0 0 _aChronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
_h[electronic resource]
260 _bCell cycle (Georgetown, Tex.)
_cDec 2008
300 _a3810-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAtaxia Telangiectasia Mutated Proteins
650 0 4 _aCell Cycle Proteins
_xgenetics
650 0 4 _aChromosomes, Human, Pair 17
650 0 4 _aDNA Damage
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aGene Deletion
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aProtein Serine-Threonine Kinases
_xgenetics
650 0 4 _aSurvival Analysis
650 0 4 _aTumor Suppressor Protein p53
_xgenetics
650 0 4 _aTumor Suppressor Proteins
_xgenetics
700 1 _aBenner, Axel
700 1 _aDöhner, Hartmut
700 1 _aStilgenbauer, Stephan
773 0 _tCell cycle (Georgetown, Tex.)
_gvol. 7
_gno. 24
_gp. 3810-4
856 4 0 _uhttps://doi.org/10.4161/cc.7.24.7245
_zAvailable from publisher's website
999 _c18549527
_d18549527